|
bioMerieux gmbh
hiv-1 rna easyq reagent kit Hiv 1 Rna Easyq Reagent Kit, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hiv-1 rna easyq reagent kit/product/bioMerieux gmbh Average 90 stars, based on 1 article reviews
hiv-1 rna easyq reagent kit - by Bioz Stars,
2026-04
90/100 stars
|
Buy from Supplier |
|
Roche
hiv 1 rna viral load Hiv 1 Rna Viral Load, supplied by Roche, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/hiv 1 rna viral load/product/Roche Average 86 stars, based on 1 article reviews
hiv 1 rna viral load - by Bioz Stars,
2026-04
86/100 stars
|
Buy from Supplier |
|
R&D Systems
systems hiv 1 gag p24 quantikine elisa kit ![]() Systems Hiv 1 Gag P24 Quantikine Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/systems hiv 1 gag p24 quantikine elisa kit/product/R&D Systems Average 94 stars, based on 1 article reviews
systems hiv 1 gag p24 quantikine elisa kit - by Bioz Stars,
2026-04
94/100 stars
|
Buy from Supplier |
|
Proteintech
anti hiv 1 p24 ![]() Anti Hiv 1 P24, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/anti hiv 1 p24/product/Proteintech Average 93 stars, based on 1 article reviews
anti hiv 1 p24 - by Bioz Stars,
2026-04
93/100 stars
|
Buy from Supplier |
|
Bio-Rad
cdc recommended geenius hiv 1 2 supplemental assay ![]() Cdc Recommended Geenius Hiv 1 2 Supplemental Assay, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cdc recommended geenius hiv 1 2 supplemental assay/product/Bio-Rad Average 95 stars, based on 1 article reviews
cdc recommended geenius hiv 1 2 supplemental assay - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
Bio-Rad
rapid hiv 1 2 antibody differentiation assays ![]() Rapid Hiv 1 2 Antibody Differentiation Assays, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rapid hiv 1 2 antibody differentiation assays/product/Bio-Rad Average 95 stars, based on 1 article reviews
rapid hiv 1 2 antibody differentiation assays - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
Bio-Rad
bio rad geenius hiv 1 2 supplemental assay ![]() Bio Rad Geenius Hiv 1 2 Supplemental Assay, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bio rad geenius hiv 1 2 supplemental assay/product/Bio-Rad Average 95 stars, based on 1 article reviews
bio rad geenius hiv 1 2 supplemental assay - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
Gilead Sciences
dose hiv therapy genvoya ![]() Dose Hiv Therapy Genvoya, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dose hiv therapy genvoya/product/Gilead Sciences Average 99 stars, based on 1 article reviews
dose hiv therapy genvoya - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
Journal: Nucleic Acids Research
Article Title: A nanopore-based HIV-1 reference epitranscriptome
doi: 10.1093/nar/gkag220
Figure Lengend Snippet: Probing and correction of HIV-1 base modifications called by nanopore dRNA-seq. ( A ) Nanopore modification-calling results for HIV-1 viral RNA extracted from Jurkat cell cultures treated with STM2457, a drug that inhibits METTL3 m 6 A modification activity. The position of each high frequency m 6 A nucleotide in the HIV-1 genome is indicated on the x -axis. ( B ) Comparison of modifications at DRACH motif sites where m 6 A was called at high frequency. The nucleotide position of the m 6 A modification within the DRACH motif is indicated on the x -axis. Upper plot: comparison of Jurkat cell samples infected with HIV-1 without (back row) or with (front row) 30 μM STM2457 treatment. Lower graph: comparison of Jurkat cell sample infected with HIV-1 before (back row) and after (front row) baseline correction. Comparison of modification calling between NL4-3 from Jurkat cells ( C ) and two synthetic HIV-1 RNA fragments, one unmodified ( D ) and one bearing m 6 A ( E) at two DRACH motifs. The nucleotide position corresponding to the NL4-3 genome is indicated on the x -axis. All modifications called in panel (D) are considered incorrect while modifications called in panel (E), besides m 6 A at position 8975 and 8989, are considered incorrect.
Article Snippet: For replicative NL4-3, we concentrated the supernatants over a 20% sucrose cushion at 5600 × g overnight in 15 ml tubes. p24 ELISA was performed to quantify the viral preparations (
Techniques: Modification, Activity Assay, Comparison, Infection
Journal: Nucleic Acids Research
Article Title: A nanopore-based HIV-1 reference epitranscriptome
doi: 10.1093/nar/gkag220
Figure Lengend Snippet: Nanopore-based modification calling of the most reliable, baseline-subtracted HIV-1 RNA modifications on viral RNA from Jurkat cells. The HIV-1 genome architecture is illustrated above. Modifications are shown if, after baseline correction, the average modification frequency was at least 10%. ( A ) m 6 A (blue), ( B ) m 5 C (green), ( C ) pseudouridine (psi) (yellow), ( D ) inosine (purple), and ( E ) 2′- O -methylation (orange). Inset in panel (A) is a close-up of the 3′ end of the NL4-3 HIV-1 genome where m 6 A is most densely called. Results are the average of three separate biological replicates. Error bars are standard deviation.
Article Snippet: For replicative NL4-3, we concentrated the supernatants over a 20% sucrose cushion at 5600 × g overnight in 15 ml tubes. p24 ELISA was performed to quantify the viral preparations (
Techniques: Modification, Methylation, Standard Deviation
Journal: Nucleic Acids Research
Article Title: A nanopore-based HIV-1 reference epitranscriptome
doi: 10.1093/nar/gkag220
Figure Lengend Snippet: Differential modification frequencies in HIV-1 RNA splice isoforms. Comparison of modification frequency in each splice isoform as compared to the full-length (unspliced) isoform. X -axis represents individual nucleotides in the HIV-1 genome. Y -axis represents percentage of reads that contained the mutation of interest for that nucleotide, relative to the unspliced form. Bar color indicates modification type: m 6 A (blue), m 5 C (green), pseudouridine (yellow), inosine (purple), and 2′- O -methyl (orange). Only modifications with a difference of 10% from the unspliced RNA in at least one isoform are shown. Shaded background shows portion of the full transcript retained in the spliced isoform. Splice isoforms are subsets of direct-RNA sequencing sample 7C. The A6 splice site is exclusive to the HXB2 genome and therefore not indicated here.
Article Snippet: For replicative NL4-3, we concentrated the supernatants over a 20% sucrose cushion at 5600 × g overnight in 15 ml tubes. p24 ELISA was performed to quantify the viral preparations (
Techniques: Modification, Comparison, Mutagenesis, RNA Sequencing
Journal: Nucleic Acids Research
Article Title: A nanopore-based HIV-1 reference epitranscriptome
doi: 10.1093/nar/gkag220
Figure Lengend Snippet: A preliminary HIV-1 antisense epitranscriptome, the effect of cART and cell type on HIV-1 modification calling, and conservation of m 6 A in HIV-1 genomes from PLWH. (A) Nanopore modification-calling for HIV-1 antisense RNA from Jurkat cells. m 6 A (blue), m 5 C (green), pseudouridine (yellow), inosine (purple), and 2′- O -methylation (orange). Inset shows a close-up of the asp gene. (B) Nanopore modification-calling results for HIV-1 RNA taken from Jurkat cells treated without (darker color) or with (lighter color) cART treatment. Error bars represent the standard deviation from three separate biological replicates. (C) Nanopore modification-calling results for HIV-1 RNA taken from Jurkat cells, primary CD4+ T cells infected in vitro , supernatant of primary CD4+ T cells infected in vitro , and CD4+ T cells from PLWH samples. In each nucleotide position cluster, the first bar is Jurkat cell samples infected with HIV-1, the second bar is CD4+ T cells from healthy donors and infected with HIV-1, the third bar is the supernatant from the CD4+ T cells from healthy donors, and the fourth, fifth, and sixth bars are samples taken from CD4+ T cells from PLWH donors. (D) Top: comparison of m 6 A modifications called from HIV-1 RNA from Jurkat cells against preservation of the DRACH motifs for these m 6 A modifications sequenced from three PLWH samples. Bottom: analysis of conservation of known m 6 A modification sites in a larger dataset of HIV-1 mutations. Positions containing m 6 A between nucleotide positions 8000 and 9171 were identified and the average and median Shannon entropy for these positions are reported.
Article Snippet: For replicative NL4-3, we concentrated the supernatants over a 20% sucrose cushion at 5600 × g overnight in 15 ml tubes. p24 ELISA was performed to quantify the viral preparations (
Techniques: Modification, Methylation, Standard Deviation, Infection, In Vitro, Comparison, Preserving